Space Biotechnology Group (SBG)

Space Biotechnology Group (SBG)




Space Biotechnology Group (SBG) is a high-tech enterprise specializing in the space biotechnology industry, established as a joint venture between China Aerospace Science and Technology Corporation (CASC) and China Resources Group, and is the first batch of landing projects of strategic cooperation between CASC and China Resources Group. SBG has 2 subsidiary holding companies and 3 shareholding companies. Its main qualifications include national high-tech enterprise,the Space Biology Research Department of Qian Xuesen Laboratory of Space Technology,the Beijing Space Biology Engineering Research Center, and the "National Demonstration Base for Attracting Talents and Wisdom" of the Ministry of Science and Technology, etc.


With the help of spaceflight technologies and resources, SBG has carried out a number of biotechnology and product development research and industrialization, gradually forming core businesses such as space life science and biomedical experiment services, biological APIs and space breeding.


SBG seizes the historical opportunity of the construction and operation of China's space station,cooperates with leading biomedical teams at home and abroad,focuses on strategic emerging fields such as biomedicine, bioinformatics and new materials,strengthens the business of space science experiments;SBG strengthens benchmarking with leading enterprises in the pharmaceutical and medicine industries, introduces strategic shareholders of leading enterprises in the pharmaceutical and medicine industries, carries out in-depth cooperation in the fields of research and development, production and sales of biological APIs,resolves major operational risks and continuously improves profitability and market competitiveness; Focusing on the application of space technology in biotechnology and new materials, SBG will acquire high-quality target companies to quickly build a new business base to support future development.


SBG will seek progress in a stable manner and strive to become a "key link" in China's space biomedical industry chain.